Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$54.02
neg -0.77
-1.40%
Today's Range: 54.02 - 54.83 | TEVA Avg Daily Volume: 6,154,600
Last Update: 07/29/16 - 10:02 AM EDT
Volume: 276,774
YTD Performance: -16.53%
Open: $54.77
Previous Close: $54.79
52 Week Range: $48.01 - $71.68
Oustanding Shares: 914,000,000
Market Cap: 50,416,240,000
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.53 1.53 1.53
Latest Dividend: 0.29
Latest Dividend Yield: 2.10%
Dividend Ex-Date: 05/20/16
Price Earnings Ratio: 30.31
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
30.31 28.70 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.36% -23.27% 34.52%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 0.00 -0.01
Net Income -47.50 -0.20 -0.06
EPS -48.90 -0.20 -0.06
Earnings for TEVA:
EBITDA 5.79B
Revenue 19.65B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.17 $1.41 $5.14 $5.70
Number of Analysts 5 5 8 8
High Estimate $1.20 $1.45 $5.32 $6.14
Low Estimate $1.14 $1.36 $4.64 $4.63
Prior Year $1.43 $1.35 $5.42 $5.14
Growth Rate (Year over Year) -18.04% 4.59% -5.21% 10.97%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The stock has broken free of tiresome resistance in a big way.
I expect Allergan or another player to bid for SGYP soon.
Bearish
Jul 15, 2016 | 7:15 AM EDT
TEVA was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $60 price target.
The drug maker is a compelling buy and has 50% upside potential over the next 18 to 24 months.

My Takeaways and Observations Real Money Pro($)

The U.S. dollar weakened a tad. The price of crude oil rose by over $2 to $46.79. Gold fell by $22.70 to $1,333. The commodity broke out at $1,300, so support seems to be there. Agricultural commodities: wheat +6, corn +5, soybean +31 (!), oats flat. Lumber +3. Bonds schmeissed. iShares 20+ Year Treasury Bond ETF (TLT) down $2.20. The yield on the 10-year rose by eight basis points to 1.51%. The long bond yield rose nine basis points to 2.23%. The 2s/10s rose to 84 basis points. Municipals were hit small, but closed-end funds got smashed. Several muni bond funds were down by more than 2%. High yield was stronger, despite the decline in the taxable fixed-income market. Banks continued higher. So did brokerages and insurance, led by Goldman Sachs (GS) , up $5, and Lincoln National (LNC) , up $1.85.. Retail was mixed, led by Nike (NKE) to the upside and Home Depot (HD) and Walmart (WMT) to the downside Biotech disappointed. iShares Nasdaq Biotechnology ETF (IBB) was up only $1.50. After the close Teva Pharmaceuticals (TEVA) raised guidance. Autos continued strong down the track. I covered most of my auto shorts in the Brexit period and I am close to re-shorting on the recent strength. Peak autos, I say, again. Ag equipment, which was sold on the rumor of a big crop, was bought on that news today. Staples did little. Old tech was broadly higher, with IBM (IBM) leading to the upside. Media was weak, with Disney (DIS) barely up and Comcast (CMCSA) (recently covered) lower. (T)FANG was disappointing. Telsa (TSLA) and Amazon (AMZN) were lower. Trade of the Week, short Netflix (NFLX) , was up a beaner. In individual stocks, DD was the world's fair (now up $5 from my incremental buy last week) as was Radian Group (RDN) , up another 4% and now up 18% since last week's inclusion as Trade of the Week. Oaktree Capital Group (OAK) was flat, and so was Hartford Financial Services Group (HIG) (disappointing, considering its insurance peers' strength). Starbucks (SBUX) , a short, hurt me (up $1.10). Another short, Apple (AAPL) , was up a large fraction. Here are some fine and value-added contributions from our peeps today: Jim "El Capitan" Cramer really likes Alcoa (AA) , and because of it I am doing more serious work on this name now.  Tim "Not Judy or Phil" Collins takes a non-consensus view on Delta Air Lines (DAL) ; I like this piece.  Tom Graff on what would it take for rates to rise.  Say it ain't so -- Ben "Goldfinger" Cross says gold is looking wobbly. Honest and flexible, Ben, in his approach to the precious commodity.  Tony Owusu takes a look at Amazon's Prime Day.   
They need to do something that makes them stand out as stocks you want to own, not avoid.
Tesla shares sink on delivery miss while Goldman Sachs looks to curb spending within its asset-management division.
Allergan and retailers are just a couple of examples.
We expect an upward revision in AGN's valuation multiple after the generics deal with Teva.
Allergan's stock may start to realize the potential already seen by several Real Money analysts and contributors.

Columnist Conversations

Markets set to open slightly lower as second quarter GDP comes in at a much lower than expected 1.2% and first...
I have a new non-trade-related article published on Seeking Alpha today. http://seekingalpha.com/articl...
From Real Money's Tony Owusu: Amazon (AMZN) continued its strong run of success Thursday afternoon following...
Markets mixed as we head to the last hour of trading.  Oil continues to fall and edgy closer and closer t...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.